Fundraising FoxRoche Venture Fund — 2018 Investments
2 investments dated 2018 · listed companies and verified rows first · show all
BiotechWatertown, US
Edward Mascioli(Executive Officer)Andrew Myers(Director)
BoardMarkus Goebel(Director)Henry Skinner(Director)inVikas Goyal(Director)Raj Parekh(Director)in
Board seatAnja Harmeier· per SEC Form D · $20M raise · filed Mar 2018
Co-investorsAdvent Life SciencesGurnet Point CapitalNovartis Venture Fund
NMD Pharma is a clinical-stage biotech company developing first-in-class small-molecule therapies that selectively target skeletal muscle to treat rare neuromuscular diseases and age-related conditions.
BiotechDeep TechHealthtechMedical DevicesAarhus, DK
Co-investorsJeito CapitalNovo HoldingsInkefLundbeckfonden Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.